Treatment
Somapacitan clinical trials
We’re tracking 3 recruiting studies that include Somapacitan, each written for real people, not researchers, below.
Recruiting studies
- NCT06709040Enrolling by invitation
Long-term safety of somapacitan in children with growth hormone deficiency
This study is watching children who are already taking somapacitan (a growth hormone injection) to see if it is safe over a long time. It collects information about growth and any side effects.
Glasgow, ScotlandAges Up to 18 years - NCT06109935Enrolling by invitation
Long-term study of Sogroya for children with growth hormone deficiency
This trial is looking at how well Sogroya® (a growth hormone medicine) works when used for a long time in children with short stature caused by growth hormone deficiency. The goal is to see if it helps them grow taller safely.
AichiAges birth–18 years - NCT05718570Enrolling by invitation
Long-term follow-up for adults taking Sogroya for growth hormone deficiency
This study follows adults with growth hormone deficiency who start (or have started) Sogroya to learn about its long-term safety. It does not change your treatment—it mainly checks for side effects and health outcomes over time.
Phoenix, ArizonaAges 18 years+
What Somapacitan is being studied for
Conditions with recruiting Somapacitan studies.
Common questions
- Are there clinical trials studying Somapacitan?
- Yes. Clin2 currently lists 3 recruiting studies that include Somapacitan, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Somapacitan trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Somapacitan an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Somapacitan or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.